July 18 (Reuters) - 9 Meters Biopharma said the drug developer and its unit have filed for Chapter 11 bankruptcy protection, according to a regulatory filing on Tuesday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 14 | |
+180.51% | 8.67B | |
+2.29% | 983M | |
+41.91% | 883M | |
+26.17% | 825M | |
+1.92% | 665M | |
+9.52% | 664M | |
-.--% | 600M | |
+9.17% | 530M | |
-.--% | 500M |
- Stock Market
- Equities
- NMTRQ Stock
- News 9 Meters Biopharma, Inc.
- Drug developer 9 Meters Biopharma files for bankruptcy protection